APA

Ditschkowski M., Haferlach C., Schulte C., Trenschel R. & Beelen D. W. (20091214). Occurrence of AML in cells of donor origin after treatment of CML in relapse with imatinib and donor stem cell boost 16 years after the original allogeneic BMT. : Bone marrow transplantation.

Chicago

Ditschkowski M, Haferlach C, Schulte C, Trenschel R and Beelen D W. 20091214. Occurrence of AML in cells of donor origin after treatment of CML in relapse with imatinib and donor stem cell boost 16 years after the original allogeneic BMT. : Bone marrow transplantation.

Harvard

Ditschkowski M., Haferlach C., Schulte C., Trenschel R. and Beelen D. W. (20091214). Occurrence of AML in cells of donor origin after treatment of CML in relapse with imatinib and donor stem cell boost 16 years after the original allogeneic BMT. : Bone marrow transplantation.

MLA

Ditschkowski M, Haferlach C, Schulte C, Trenschel R and Beelen D W. Occurrence of AML in cells of donor origin after treatment of CML in relapse with imatinib and donor stem cell boost 16 years after the original allogeneic BMT. : Bone marrow transplantation. 20091214.